Publicatie

Publicatie datum

Personalized medication overview (MijnGiB): insights from patients and (in)formal caregivers after first encounter and after one-month patient use. Part B) Qualitative study.

Schackmann, L., Vervloet, M., Tomic, M., Dijk, L. van. Personalized medication overview (MijnGiB): insights from patients and (in)formal caregivers after first encounter and after one-month patient use. Part B) Qualitative study. Utrecht: Nivel, 2022. 27 p.
Download de PDF
The instructions on prescription medication labels are not always well-understood by patients. Consequently, a common cause of medication errors is the (in)comprehensibility of medication information, particularly the prescription medication label instructions.

In a previous experiment, we investigated the comprehensibility of prescription label instructions for people who were exposed vs. not exposed to a personalized medication overview and whether an increasing number of prescribed medications had an influence on the comprehensibility of the instructions. The results of this experiment show that the personalized medication overview, My Medication Review, [in Dutch: Mijn Geneesmiddel in Beeld® (MijnGiB)], can support patients specifically for the extra information presented on the overview, which is not presented on the usual-care prescription medication labels; such as warnings and for which complication one should use the medication.

The next key step after the experiment, as part of a larger study, was to delve deeper into the opinions and experiences of the users of MijnGiB. The aim of this study was to gain insights into the opinions and experiences of patients and (in)formal caregivers regarding MijnGiB after seeing the overview for the first time, and to assess patient experiences after having used MijnGiB for one month.